Goxalapladib

CAS No. 412950-27-7

Goxalapladib( —— )

Catalog No. M35993 CAS No. 412950-27-7

Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 276 In Stock
10MG 394 In Stock
25MG 616 In Stock
50MG 830 In Stock
100MG 1097 In Stock
200MG 1507 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Goxalapladib
  • Note
    Research use only, not for human use.
  • Brief Description
    Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
  • Description
    Goxalapladib(GSK 677116) is a small molecule compound that can be used to treat cardiovascular risks associated with atherosclerosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    412950-27-7
  • Formula Weight
    718.75
  • Molecular Formula
    C40H39F5N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(N(CC1=CC=C(C=C1)C2=CC=C(C(F)(F)F)C=C2)C3CCN(CCOC)CC3)=O)N4C=5C(C(=O)C=C4CCC6=C(F)C(F)=CC=C6)=CC=CN5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • beta-Escin

    beta-Escin is a natural mixture of triterpenoid saponins isolated from horse chestnut (Aesculus hippocastanum) seeds.

  • Heraclenol

    (-)-Heraclenol shows in vitro anti-plasmodial activity against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.(-)-Heraclenol has moderate antibacterial and antifungal activities.

  • Linoleic Acid Amide

    Linoleic acid amide is a primary fatty acid amide derived from linoleic acid . It is reported to regulate Ca2+ flux by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (IC50 = 15-53 µM).